CSL announces Chairman-elect and a new director

Company News

by Jessica Amir

Global biotechnology company, CSL (ASX:CSL) has named Dr Brian McNamme as its Chairman elect, in lieu of Professor John Shine’s resignation.

John Shine has been on the board for 11 years with 8 years at the helm.

At the same time, CSL announced its new Chairman elect, Dr Brian McNamme has been appointed a new independent non-executive director with effect from 14 February 2018.

Brian was the company's CEO and MD for 23 years before he retired in 2013.

CSL also appointed the previous Global President of GlaxoSmithKline, Abbas Hussain as a new independent non-executive director, to bring ‘additional biotech insights to the board’ ..

Shares in CSL (ASX:CSL) are trading 0.38 per cent higher to $141.14

Jessica Amir

Finance News Network
Jessica is the head of news and a senior finance journalist and presents bulletins including the Market Outlook, Market at Midday and Market Wrap. She also interviews ASX CEOs and leading fund managers. She joined FNN in January 2017 with over six years of broadcast journalism experience including with Sky News Business, ABC 1, ABC's The Business and ABC24. She’s also worked as a TV reporter for Prime 7 and WIN News. Jessica has worked in financial planning for over six years with leading wealth managers and in real estate.